Dimpi Desai retweeted
🩺 Picture this patient:
BMI 38. New-onset type 2 diabetes. No other comorbidities.
Every clinician instinctively recognizes this as an adiposity-driven disease process that merits intensive intervention — lifestyle, pharmacotherapy, possibly metabolic surgery.
❌ Under the Lancet Commission framework, this patient has "preclinical obesity."
That's because T2DM is not among the obesity-related organ dysfunctions that qualify for a clinical obesity diagnosis.
🤔 Yet the framework simultaneously includes OSA, atrial fibrillation, heart failure with preserved ejection fraction, and pulmonary hypertension as qualifying conditions — all of which are also multifactorial and can occur without obesity.
✅ Clinical obesity: HbA1c 6.1% + dyslipidemia → metabolic cluster met
❌ Preclinical obesity: HbA1c 6.8% (T2DM) + normal lipids → T2DM excluded from criteria
⚠️ T2DM has been a principal qualifier for obesity pharmacotherapy and bariatric surgery for decades. Removing it from the diagnostic construct risks confusing payers and delaying access for the patients who need it most.
Read our recent paper for more:
🔗 academic.oup.com/jcem/advanc…
I’m glad to share our recent guideline communication through the @TheEndoSociety
Obesity is a global pandemic and
there is an increasing need for diagnostic approaches that are practical and equitable.
academic.oup.com/jcem/advanc…
@dr_muniyappa @MWeintraubMD @TChukir
Dimpi Desai retweeted
New @TheEndoSociety guideline communication appraises the The Lancet Commission obesity framework. We explore implications for practice and policy.
@MWeintraubMD @RothbergAmy
@TChukir @dimpi_desai
@BevTchangMD @MichaelMindrum @MichaelAlbertMD
academic.oup.com/jcem/articl…
Excited to kick off Year 2 of the Medical Student Engagement Program! 🎉
Great turnout of 1st-year med students for faculty meet-and-greet + an inspiring fellow presentation.
Early exposure to endocrinology = early sparks of curiosity 💡
Thanks @TheEndoSociety @JoyYWu
Feeling incredibly grateful and humbled to be promoted to Clinical Associate Professor in the Division of Endocrinology at Stanford. Thank you to the mentors, colleagues, and trainees who have supported and inspired me every step of the way.💛 @StanfordEndo
I’m honored to be speaking at the Stanford Big Ideas in Medicine Conference this Sept 5–6. It’s a space where people from health, science, and storytelling come together to imagine what care could look like in the future. Grateful to be part of the conversation !@StanfordMedMuse
7
248
Congratulations to the new Golden State Obesity Society on their 1st annual conference!
Honored to speak on “Connecting the Dots: Diabetes & Obesity” at this inspiring event
Grateful to join a great group of speakers & organizers @DrAmanRajpal @ShagunBindlish
Inspired by #ENDO2025, we’re continuing strong into Year 2 of Stanford’s Medical Student Engagement Program!
Yesterday’s session on thyroid storm & DKA sparked great discussion—led by our amazing faculty & fellows, and joined by new med students. @TheEndoSociety @StanfordEndo
Thank you @TheEndoSociety for the wonderful meeting #ENDO2025. Returned to work today inspired and rejuvenated! Looking forward to ENDO 2026 at Chicago!!
Continuing our yearly tradition of a 7am breakfast at #ENDO2025 with my former program director, the incredible Dr. Susan Mandel, and one of her former fellows, Dr. Katie Guttenberg. Always a joy to catch up! @TheEndoSociety #ENDO2025
Thank you @TheEndoSociety for the wonderful MSEP reception. We are honored to have received the MSEP award and our students had a fabulous time at #ENDO2025.
The best part of ENDO is the people you reconnect with! Attending a session with friends from my medical school! @ashnidharia98 @ektatirthani @TheEndoSociety #ENDO2025
Our fellow Dr. Tugce Akcan presenting at #ENDO2025 on real-world use of verapamil in Type 1 diabetes.
Incredible work from the @StanfordEndo team. @TheEndoSociety #ENDO2025
Live at #ENDO2025!
Our fellow Dr. Angela Rao is presenting our study on perioperative GLP-1 use in bariatric surgery.
Patients on GLP-1s before and after surgery saw the greatest weight loss. Proud of this collaboration
@StanfordEndo @AngieRao92 @dazagury @TheEndoSociety
Thank you @jubinsanghavi for taking care of our kids while I go attend #ENDO2025 @TheEndoSociety
Excited to see so many @StanfordEndo presentations at ENDO 2025 this weekend in SF! Grateful to be part of a community—from students to faculty—driving endocrine science forward.
🔗 mailchi.mp/8960b17fe2c8/stan…
#ENDO2025 @JoyYWu
This quoted post is unavailable.
Thyroid disorders and obesity often coexist, creating diagnostic and management challenges. Our latest review explores the intersection of these conditions and provides a clinical approach. Kudos to @ashnidharia98 for an excellent job on this! #Endocrinology #Obesity
Thrilled to have worked on an insightful article about thyroid disorders and obesity, guided by amazing mentors!
@kanikshadesai @dimpi_desai
Exploring the Link Between Thyroid Disorders and Obesity : Mechanisms, Impacts, and Clinical Implications - endocrinepractice.org/articl…
Dimpi Desai retweeted
Delighted to host Dr. Susan Mandel, Chief of Endocrinology, Diabetes and Metabolism @PennMedicine, University of Pennsylvania Health System, to share a preview of the forthcoming American Thyroid Association, Inc. (ATA) guidelines on management of thyroid nodules.
Dimpi Desai retweeted
Grateful to @TheEndoSociety for supporting our @StanfordMed student Endocrinology Interest Group and delighted to host Robert Lash and Sacha Uelman on a site visit for our @StanfordEndo faculty meet and greet event!
Dimpi Desai retweeted
Working on the endocrinologist pipeline with support from @TheEndoSociety Medical Student Engagement Program.
Thanks to @StanfordEndo faculty members Neil Gesundheit, @dimpi_desai and Rayhan Lal for leading this evening’s Endocrinology Interest Group!



























